Dr. Keith E. Rushlow
Board Member


Dr. Rushlow has broad experience in managing basic and applied R&D in diverse environments (private and government research institute, university/academia, start-up biotech, and large company pharma/healthcare). He specializes in conducting and coordinating due-diligence efforts to assess the potential value of new technologies, products, and companies to facilitate and support risk-adjusted investment decisions in emerging R&D and new business opportunities. He performs expert analysis in determining the probability of technical and commercial success in translating early-stage technologies, product concepts, and new business models into viable and sustainable commercial opportunities.